Smith & Nephew plc (LON:SN) Given Consensus Rating of "Hold" by Brokerages

Key Points

• Smith & Nephew has a consensus “Hold” rating from nine analysts: six recommend holding the shares, while three recommend buying. The average 12-month price target is GBX 1,310.
• Several brokers recently lowered their price targets, including JPMorgan, Berenberg and Royal Bank of Canada, with targets generally ranging from GBX 1,250 to GBX 1,300.
• The stock opened at GBX 1,069.50, below its 50-day and 200-day moving averages, giving the company a market capitalization of approximately £11.72 billion.

Smith & Nephew plc (LON:SN - Get Free Report) has been assigned a consensus recommendation of "Hold" from the nine ratings firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is GBX 1,310.

A number of research analysts have recently weighed in on SN shares. JPMorgan Chase & Co. cut their price objective on Smith & Nephew from GBX 1,438 to GBX 1,290 and set a "neutral" rating on the stock in a report on Thursday, August 6th. Citigroup lowered Smith & Nephew to a "buy" rating in a research report on Friday, July 10th. UBS Group reiterated a "neutral" rating and issued a GBX 1,300 price target on shares of Smith & Nephew in a report on Tuesday, May 5th. Berenberg Bank cut their price target on shares of Smith & Nephew from GBX 1,300 to GBX 1,250 and set a "hold" rating on the stock in a report on Friday, August 14th. Finally, Royal Bank Of Canada reduced their price target on shares of Smith & Nephew from GBX 1,350 to GBX 1,250 and set a "sector perform" rating for the company in a research report on Thursday, August 6th.

Smith & Nephew Trading Down 0.4%

LON SN opened at GBX 1,069.50 on Friday. The business has a 50-day moving average of GBX 1,129.08 and a two-hundred day moving average of GBX 1,183.24. The company has a current ratio of 2.14, a quick ratio of 0.84 and a debt-to-equity ratio of 73.07. The stock has a market capitalization of £11.72 billion, a PE ratio of 38.51, a P/E/G ratio of 0.46 and a beta of 0.69.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source